Subcommittee OKs bill requiring coverage for provider-ordered biomarker testing

Mar 12, 2025

House Bill 484, sponsored by Chairman Martin, was amended and passed by the Insurance Subcommittee to require coverage of provider-ordered biomarker (biomarker) testing for diagnosis and treatment management; supporters said the tests can improve targeted cancer care and reduce long-term costs.

The full story

The Insurance Subcommittee voted 6-0 to pass an amended House Bill 484, which requires coverage of provider-ordered biomarker testing when used for diagnosis, treatment, and ongoing management of conditions, according to the sponsor.

Free newsletter

Sign up to keep reading.

Your free newsletter brings you what your city council, county, and school board discussed and decided.

or
Already have an account? Sign in